index
  :: Home :: Contact :: Site Map
  Search:
index
Event Overview
Register
Speaker List
Detailed Agenda
Price/Info
Venue
Exhibitors and Sponsors
Poster Guidelines
Refer A Friend
Submit an Abstract
Other Conferences
Home
 
 
7th Annual Vaccines: All Things Considered
 

 


 

Dear Colleague,

GTCbio is proud to present its 7th Annual Vaccines: “All Things Considered” conference to be held in Washington, D.C. on Nov 9-10, 2009. This conference promises to be the one-stop destination for valuable updates and exposure on all aspects of vaccine research, development, regulations, and policy.

The research and discovery of vaccines to fight globally prevalent diseases has been a major focus of the pharmaceutical industry’s biggest players for decades. The pharmaceutical world has recently been rocked by the pending expiration of patents on several major block-buster drugs. How does this affect funding for vaccine research and development? What will be the path forward? How will the generic drug industry affect the vaccines market? These are just a few of the questions the Vaccines conference will address and answer.

Recent advancements in the discovery of novel vaccines that target not only traditional infectious diseases (such as Malaria, Influenza, AIDS, Meningitis, etc), but non-infectious diseases (such as cancer, allergies, and even smoking) as well, prove to be both innovative and promising for the industry. The Vaccines conference is the perfect forum to network with colleagues and gain valuable information on these exciting next generation vaccines.

In the spirit of truly considering all things, GTCbio’s Vaccines conference also brings together leading government officials, such as representatives from the DHHS and the FDA, to provide a first-hand perspective into current US vaccines policy and regulation. Updates on the pandemic and bio-defense policy as well as the National Vaccine Plan will be addressed and discussed..

Gaining a proficient understanding of, and accounting for, the aforementioned factors is vital before moving forward with Vaccine discovery and development. Don’t miss an opportunity to take all things into consideration and register for GTCbio’s 7th Annual Vaccines: “All Things Considered” conference.
 

Sincerely,

2009 Vaccines: All Things Considered Organizing Committee

 

FEATURED PARTNER PUBLICATION:


Upgrade! Add One Additional Conference for only $400 more! Attend ONE Additional Conference of your choice for only $400 more. Click here to sign up!
   
All Conference Pass! Attend ALL 2009 Conferences. Attend ALL 2009 GTCbio Conferences for only $3000.
Click here to sign up!
 
KEYNOTE SPEAKER:

Konstantin Pugachev
Director, Head of the Virology Department
Sanofi Pasteur

 
SPONSORS:



 

MEDIA PARTNERS:


Journal of Immunological Methods

PharmaVoice

Virtual Medical Centre
 

 
index
  :: Conferences :: Exhibit and Sponsor :: Contact us :: Employment :: Request Info  
Copyright © 2006 Global Technology Community, LLC